SG11202010294RA - Compositions for the treatment of skin conditions - Google Patents
Compositions for the treatment of skin conditionsInfo
- Publication number
- SG11202010294RA SG11202010294RA SG11202010294RA SG11202010294RA SG11202010294RA SG 11202010294R A SG11202010294R A SG 11202010294RA SG 11202010294R A SG11202010294R A SG 11202010294RA SG 11202010294R A SG11202010294R A SG 11202010294RA SG 11202010294R A SG11202010294R A SG 11202010294RA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- treatment
- skin conditions
- skin
- conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862659566P | 2018-04-18 | 2018-04-18 | |
| US201862703742P | 2018-07-26 | 2018-07-26 | |
| PCT/US2019/027912 WO2019204475A1 (en) | 2018-04-18 | 2019-04-17 | Compositions for the treatment of skin conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202010294RA true SG11202010294RA (en) | 2020-11-27 |
Family
ID=68236163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202010294RA SG11202010294RA (en) | 2018-04-18 | 2019-04-17 | Compositions for the treatment of skin conditions |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20190321416A1 (en) |
| EP (1) | EP3784260A4 (en) |
| JP (1) | JP2021522323A (en) |
| KR (1) | KR20210011926A (en) |
| CN (1) | CN112512540A (en) |
| BR (1) | BR112020021274A2 (en) |
| CA (1) | CA3097607A1 (en) |
| CL (1) | CL2020002679A1 (en) |
| GB (1) | GB2589729A (en) |
| MX (1) | MX2020011016A (en) |
| SG (1) | SG11202010294RA (en) |
| WO (1) | WO2019204475A1 (en) |
| ZA (1) | ZA202006610B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10293005B2 (en) | 2016-04-19 | 2019-05-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of gram negative species to treat atopic dermatitis |
| CN109310626A (en) | 2016-04-19 | 2019-02-05 | 美利坚合众国,由健康及人类服务部部长代表 | The purposes of Gram-negative kind treatment atopic dermatitis |
| WO2021138599A1 (en) * | 2020-01-03 | 2021-07-08 | Forte Subsidiary, Inc. | Cosmetic compositions |
| US20230033663A1 (en) * | 2020-01-17 | 2023-02-02 | Second Genome, Inc. | Methods and compositions for treating atopic dermatitis |
| KR102558085B1 (en) * | 2021-09-08 | 2023-07-24 | 코스맥스 주식회사 | Bifidobacterium animalis subsp. lactis strain and its use for improving skin conditions |
| EP4183403A1 (en) | 2021-11-19 | 2023-05-24 | Lietuvos Sveikatos Mokslu Universitetas | Modification of fecal microbiota with capsules containing gram-positive bacteria |
| CN115140846B (en) * | 2022-07-06 | 2024-06-21 | 江苏聚庚科技股份有限公司 | Composite treating agent, preparation method and application thereof in purifying wastewater |
| CN116407565B (en) * | 2023-03-15 | 2023-10-31 | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | Application of active rhodomonas mucilaginosa preparation and extracellular polysaccharide thereof in preparation of medicines for treating psoriasis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2448577T3 (en) * | 2009-06-30 | 2017-02-28 | Derman Biomedicine Co. Ltd. | Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders |
| US20120076738A1 (en) * | 2010-09-28 | 2012-03-29 | Michael Graeber | Combination treatment for dermatological conditions |
| KR20160032725A (en) * | 2013-07-11 | 2016-03-24 | 마이크레오스 휴먼 헬스 비.브이. | Combination treatment for atopic dermatitis |
| MA41020A (en) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND THEIR METHODS OF USE FOR MODULATION OF THE MICROBIOME |
| US10774305B2 (en) * | 2015-04-20 | 2020-09-15 | S-Biomedic Nv | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains |
| CN109310626A (en) * | 2016-04-19 | 2019-02-05 | 美利坚合众国,由健康及人类服务部部长代表 | The purposes of Gram-negative kind treatment atopic dermatitis |
-
2019
- 2019-04-17 MX MX2020011016A patent/MX2020011016A/en unknown
- 2019-04-17 WO PCT/US2019/027912 patent/WO2019204475A1/en unknown
- 2019-04-17 KR KR1020207033274A patent/KR20210011926A/en unknown
- 2019-04-17 GB GB2017321.7A patent/GB2589729A/en not_active Withdrawn
- 2019-04-17 US US16/386,736 patent/US20190321416A1/en not_active Abandoned
- 2019-04-17 CA CA3097607A patent/CA3097607A1/en not_active Abandoned
- 2019-04-17 EP EP19788131.1A patent/EP3784260A4/en not_active Withdrawn
- 2019-04-17 SG SG11202010294RA patent/SG11202010294RA/en unknown
- 2019-04-17 CN CN201980041448.9A patent/CN112512540A/en active Pending
- 2019-04-17 BR BR112020021274-1A patent/BR112020021274A2/en not_active Application Discontinuation
- 2019-04-17 JP JP2021506367A patent/JP2021522323A/en active Pending
-
2020
- 2020-10-09 US US17/067,544 patent/US20210228650A1/en not_active Abandoned
- 2020-10-09 US US17/067,560 patent/US20210236562A1/en not_active Abandoned
- 2020-10-16 CL CL2020002679A patent/CL2020002679A1/en unknown
- 2020-10-23 ZA ZA2020/06610A patent/ZA202006610B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2589729A (en) | 2021-06-09 |
| CA3097607A1 (en) | 2019-10-24 |
| CN112512540A (en) | 2021-03-16 |
| CL2020002679A1 (en) | 2021-04-30 |
| JP2021522323A (en) | 2021-08-30 |
| US20210236562A1 (en) | 2021-08-05 |
| WO2019204475A1 (en) | 2019-10-24 |
| US20210228650A1 (en) | 2021-07-29 |
| MX2020011016A (en) | 2021-01-29 |
| EP3784260A1 (en) | 2021-03-03 |
| KR20210011926A (en) | 2021-02-02 |
| GB202017321D0 (en) | 2020-12-16 |
| ZA202006610B (en) | 2022-08-31 |
| EP3784260A4 (en) | 2022-03-09 |
| BR112020021274A2 (en) | 2021-04-13 |
| US20190321416A1 (en) | 2019-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202007055B (en) | Compositions for the treatment of skin conditions | |
| ZA202006610B (en) | Compositions for the treatment of skin conditions | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| HK1256721A1 (en) | Compounds and compositions for the treatment of ocular disorders | |
| IL276482A (en) | Compounds for the treatment of pain | |
| IL272601A (en) | Pharmaceutical compositions for the treatment of ophthalmic conditions | |
| IL272937A (en) | Compositions and methods for the treatment of fibrotic diseases | |
| SI3573620T1 (en) | Compositions for the treatment of hypertension | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| EP3813872A4 (en) | Compositions for the treatment of skin conditions | |
| IL270927B (en) | 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases | |
| PL3823655T3 (en) | Compositions for the treatment of vulvodynia | |
| IL289687A (en) | Compositions for the treatment of hair loss | |
| IL276228A (en) | Compounds and compositions for the treatment of pain | |
| IL280262A (en) | Compositions and methods for the treatment of cancer | |
| ZA202006591B (en) | Compositions for the treatment of hypertension | |
| GB201908076D0 (en) | Skin treatment composition | |
| IL263336B (en) | Compositions for treatment of symphysiolysis | |
| GB201901130D0 (en) | Formulation for the treatment of tendinopathies | |
| ZA201904327B (en) | Treatment of skin conditions | |
| GB201814764D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| GB201805556D0 (en) | Treatment of ophthalmological conditions | |
| GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| AU2017901730A0 (en) | Compositions for the Treatment of Diseases and Conditions | |
| AU2015901799A0 (en) | Composition for the treatment of skin conditions |